Quantbot Technologies’s Direxion Daily S&P Biotech Bear 3X ETF LABD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-106
Closed -$10.3K 1758
2023
Q4
$10.3K Buy
+106
New +$20.6K ﹤0.01% 1459
2022
Q3
Sell
-455
Closed -$177K 1852
2022
Q2
$177K Buy
+455
New +$228K 0.02% 964

Other funds holding LABD

Quantbot Technologies's LABD Position: Q1 2024 in Review

Quantbot Technologies sold out of Direxion Daily S&P Biotech Bear 3X ETF (LABD) in Q1 2024, closing a stake of 106 shares — an estimated $10.3K sold.

Quantbot Technologies first reported a position in LABD in Q2 2022 and held it in 2 quarters. The position peaked at $177K in Q2 2022. 21 funds tracked by Wall St. Rank hold LABD as of Q1 2024.

  • Quantbot Technologies reported no remaining Direxion Daily S&P Biotech Bear 3X ETF position as of Q1 2024 after selling out during the quarter.
  • Quantbot Technologies sold 106 Direxion Daily S&P Biotech Bear 3X ETF shares in Q1 2024, an estimated $10.3K.
  • Quantbot Technologies first reported a position in Direxion Daily S&P Biotech Bear 3X ETF in Q2 2022 and held it in 2 quarters.
  • Quantbot Technologies's Direxion Daily S&P Biotech Bear 3X ETF position peaked at $177K in Q2 2022.
  • 21 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bear 3X ETF as of Q1 2024.

Based on Quantbot Technologies's 13F filing for Q1 2024, filed 6 May 2024.